Skip to content
Screener

Telomir Pharmaceuticals, Inc. TELO Q2 2026 earnings

Reported August 13, 2026 · Before market open

EPS-$0.79Miss by $0.72
EPS estimate-$0.07

Next report

Dec 2, 2026 (in a month)
Revenue estimate$500.0K
EPS estimate-$0.03

FAQ

When did Telomir Pharmaceuticals, Inc. report Q2 2026 earnings?
Telomir Pharmaceuticals, Inc. (TELO) reported Q2 2026 earnings on August 13, 2026 before market open.
What were Telomir Pharmaceuticals, Inc.'s Q2 2026 revenue and EPS?
Telomir Pharmaceuticals, Inc. reported eps of $-0.79 for Q2 2026.
Did Telomir Pharmaceuticals, Inc. beat estimates in Q2 2026?
EPS missed the consensus estimate of $-0.07 by $0.72.
How did Telomir Pharmaceuticals, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 364.7% from $-0.17.
Where can I find Telomir Pharmaceuticals, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001493152-26-036742) and the 10-Q periodic report (0001493152-26-037854) directly on SEC EDGAR. The filing index links above go to sec.gov.